T he cost of health care in the United States is high, nearly twice that in most other developed countries, 1 and it continues to grow rapidly. The unsustainable projected trajectory of US health care costs has led to calls for improving the value of health care. 2 However, the Affordable Care Act-the most substantial policy reform in US health care in decadeshas been criticized for not doing enough to contain costs. 3 As health reform progresses, one key dynamic of the US health care system is the rapid adoption of electronic health records (EHRs). The growth of EHRs will make it possible to access unprecedented amounts of clinical data and offers the potential for cost savings. 4 The extent of those cost savings is still to be determined, 5 but EHRs' value in increasing health care providers' access to patients' records is not in question.
In other industries, companies have been very successful at using big data to improve their efficiency. 6 By big data, we refer to the high volume, variety, and potential for the rapid accumulation of data and to analytics, which is the discovery and communication of patterns in data.
Examples include Amazon's product recommendation system for online shopping, creating efficient pricing in the stock market, and predicting players' statistics in baseball. "Watson"-an application developed by IBM-had a recent success on the television quiz show Jeopardy, using some of these big-data approaches. 7 However, the extent to which these tactics will be applicable to clinical questions is as yet uncertain. 8 The underlying techniques used in big data doi: 10 have improved substantially in the past decade, and they often involve hypothesis-free approaches such as data mining. Many experts have called for health care to adopt big-data approaches, 9 but uptake has been relatively limited so far.
That may be about to change. Payment reform strategies that incentivize value such as accountable care (a key strategy of the Affordable Care Act, in which entities are asked to be "accountable" for the care they provide) and bundling (a payment approach in which providers are asked to deliver a set of services for a predefined price) are intended to motivate organizations to improve the efficiency of their care. One tactic that health care organizations will likely deploy is the more effective use of predictive analytics.
Ideally, predictive analytics will involve linking data from multiple sources, including clinical, genetic and genomic, outcomes, claims, and social data. Many new sources of data are becoming available, such as data from cell phones and social media applications. Aggregating these data for the purpose of achieving clinical predictive analytics will require the adoption of standards, 10 raise privacy and ethical concerns, 11 and require new ways to preserve privacy. 12 Big data sets can be subjected to many other types of analytic approaches, including pattern recognition and natural history-that is, the course of a disease process. However, we believe that even in the short term, it will be possible for health care organizations to realize substantial benefits from deploying predictive systems. Predictive systems are software tools that allow the stratification of risk to predict an outcome. Such tools are important because many potential outcomes are associated with harm to patients, are expensive, or both.
In health care, we suggest that one way to use predictive systems would be to identify and manage six very practical use cases-that is, examples of instances in which value is likely to be achieved. They are high-cost patients, readmissions, triage, decompensation (when a patient's condition worsens), adverse events, and treatment optimization for diseases affecting multiple organ systems (such as autoimmune diseases, including lupus). Below we address the types of data and infrastructure that health care organizations will need for each use case.We also discuss what organizations will need to do to actually improve care.
High-Cost Patients
Approximately 5 percent of patients account for about 50 percent of all US health care spending. 13 One approach to reducing costs is to identify such patients and manage them more effectively, often by having case managers work with them to improve their care. Such an approach has already resulted in cost reductions.
14 However, the identification of potentially high-cost patients has not always produced the desired results. For example, a number of Medicare demonstration projects did not lower costs even though the projects were able to identify high-risk patients. 14, 15 To effectively implement analytic methods for identifying potentially high-cost patients, a number of issues must be considered. First, what approach should be used to predict which patients who are likely to be high risk or high cost? Second, what new measurement sources can be incorporated to improve the predictions? Attributes associated with high-cost patients may include behavioral health problems or socioeconomic factors such as poverty or racial minority status. Thus, integrating data about mental health, socioeconomic status, or other issues such as marital and living status from various sources 16 may significantly change the quality of the predictions that can be made.
A third issue is how to make predictions actionable, by identifying which patients are most likely to benefit from an intervention and what specific interventions can most improve care. The effective implementation of new analytic systems to identify potentially high-cost patients will require making predictions easily available with minimal changes to clinical work flows, to increase the chances that health care providers will act on the predictions.
Many organizations and companies that currently use analytic systems have focused on identifying the algorithm that can best stratify data by risk of future costs while not addressing other issues. The variation among algorithms may not be large, and a more practical algorithm may be better than a slightly more accurate one. Algorithms are most effective and perform best when they are derived from and then used in similar populations. [17] [18] [19] A fourth issue is how to account for the fact that many cases of outcomes in predictive models often come from low-risk groups. This suggests the need for more accurate modeling, particularly for population management.
We suggest that it is important in using analytic systems to identify potentially high-cost patients to determine the patients' specific needs and gaps in care. It is especially important to identify and address behavioral health problems, because a large portion of the patients at high risk for hospital admission have some sort of behavioral health issue, with depression being especially frequent.
Programs to manage high-cost patients are expensive. They will be much more cost-effective if interventions can be precisely tailored to a patient's specific problems, which might be related to transportation, medication nonadherence, or family conflict.
Resources in health care are becoming increasingly limited, which requires greater emphasis on value. Thus, it will be important to investigate analytic techniques that identify not only highrisk people, but also those who are at particularly low risk. For instance, the standard approach may be to give all patients who are discharged from the hospital a follow-up appointment in two weeks. But it might make more sense to ensure that the highest-risk patients are seen within two days, while patients with very low risk might require follow-up care only as needed. Algorithms can help reallocate resources more effectively at both the high-risk and low-risk ends of the spectrum.
Readmissions
Much has been made of the frequency and high cost of hospital readmissions. 21 The Centers for Medicare and Medicaid Services (CMS) has strongly incentivized organizations to reduce their frequency. 22 As many as one-third of readmissions have been posited to be preventable and, therefore, to present a significant opportunity for improving care delivery. 23 Health care organizations should all use an algorithm to predict who is likely to be readmitted to the hospital. However, the predictive value of the algorithms tends to be similar. Four areas of a predictive algorithm may be important differentiators: tailoring the intervention to the individual patient, ensuring that patients actually get the precise interventions intended for them, monitoring specific patients after discharge to find out if they are having problems before they decompensate, and ensuring a low ratio of patients flagged for an intervention to patients who experience a readmission (that is, a low false positive rate).
Some work has already been done in predicting readmissions, 24 and analytics will play a key role in further work. For example, it may make sense soon to ask patients with a smartphone to allow health care organizations to access data from their phones that will help identify patients who are not managing a chronic condition well or that will monitor people recently discharged from the hospital, since it appears that patients who are not making calls or sending e-mail with their usual frequency may be depressed or suffering from other issues. 25 Patients may also be asked to wear some type of device that monitors physiological parameters, such as heart rate or rhythm. These data will be most effective in informing health care decisions if they are processed with analytics.
Triage
Estimating the risk of complications when a patient first presents to a hospital can be useful for a number of reasons, such as managing staffing and bed resources, anticipating the need for a transfer to the appropriate unit, and informing overall strategy for managing the patient. In the neonatal setting, for example, the invention of the Apgar score revolutionized the management of newborn resuscitation. 26, 27 However, computing the score required training caregivers to assess subjective parameters such as irritability and "color" (a proxy for tissue perfusion, or how well blood is flowing to tissues). In newborns and many other populations, using modern big-data techniques 28 that combine routinely collected physiological measurements makes much more accurate assessments possible with a minimal burden of training and implementation. 29 In integrating a triage algorithm into clinical work flow, it is vital to have a detailed guideline that clarifies how the algorithm will inform care. Two pilot programs in Kaiser Permanente Northern California (KPNC), an integrated health care delivery system with comprehensive information systems, are using this approach.
The first pilot involves evaluating newborns for early onset sepsis. The goal is to reduce the number of newborns who receive antibiotics unnecessarily. Hundreds of thousands of newborns are evaluated for early-onset sepsis each year. [30] [31] [32] Recently, a team of scientists from KPNC, Harvard University, and the University of California, San Francisco and Santa Cruz, developed a two-step protocol that can be expected to decrease the number of these evaluations and reduce the prescription of antibiotics for newborns dramatically in the United States. In the first One tactic that health care organizations will likely deploy is the more effective use of predictive analytics.
step, which can be embedded in an EHR, objective maternal data are used to assign a preliminary (prior to birth) probability of early-onset sepsis. 33 In the second step, a simplified set of clinical findings are combined with the estimate based on maternal data to yield a new posterior probability for risk of sepsis following birth. 34 The combination of these two steps could lead to as many as 240,000 fewer US newborns' being treated with systemic antibiotics each year.
The second KPNC pilot addresses adult patients in the emergency department. Severityof-illness scores for adult intensive care patients have been available for some time. 35, 36 However, the scores' impact on triage has been limited. This is in part because the most important of these-the Acute Physiology and Chronic Health Evaluation (APACHE) 37 and the Simplified Acute Physiology Score (SAPS) 38 -involve data that are captured after a patient has entered intensive care.
In the second pilot, clinicians in the emergency department will be provided with two composite scores that have been calibrated using millions of patient records and that are applicable to all hospitalized patients, not just those in intensive care. The first of these scores summarizes a patient's global comorbidity burden during the preceding twelve months; the second captures a patient's physiological instability in the preceding seventy-two hours. 39 In addition, these two scores, available in real time, are combined with vital signs, trends in vital signs, and other information, such as how long a patient has been in the hospital. If the information collectively indicates that a patient has ≥8 percent risk of deteriorating in the next twelve hours, an alert is sent to the responsible providers.
Importantly, the KPNC early-onset sepsis and emergency department composite score pilots are both designed for patients who are not being monitored continuously, yet they take advantage of big-data methodologies. In both cases, teams of clinicians are developing work flows that integrate big-data components (real-time risk estimates) with traditional components (such as clinical examinations and care pathways).
Decompensation
Often before decompensation-the worsening of a patient's condition-there is a period in which physiological data can be used to determine whether the patient is at risk for decompensating. Much of the initial rationale for intensive care units (ICUs) was to allow patients who were critically ill to be closely monitored. A host of technologies 40 are now available that can be used to monitor patients who are in general care units, in nursing homes, or even at home but at risk of some sort of decompensation. Realtime indices such as the Rothman Index are also available. [41] [42] [43] Some of these technologies have been available for many years, such as electrocardiographic monitoring and oxygen monitoring. Others are newer, such as end-tidal CO 2 monitoring and monitors that allow detection of whether or not a patient is moving. 44, 45 A problem with all of these technologies has been the signal-tonoise ratio: Alarms are often false positives. Monitors are becoming available in which multiple data streams can be compared simultaneously, and analytics can be used in the background to determine whether or not the signal is valid.
One example of these new monitors is a device that sits under the mattress and that collects data about the patient's respiratory rate and pulse and whether or not the patient is moving. 45 The data are transmitted to a server, where analytics are used in real time to determine if the patient appears likely to be decompensating. When the system detects a likely decompensation, an e-mail message is sent to an on-duty nurse's smartphone.
With this system, the likelihood that a true decompensation is present has been increased to approximately 50 percent-far better than for cardiac telemetry, for which it is typically 5-10 percent. In one small trial, the system reduced the number of subsequent ICU days for patients in general care units by 47 percent, compared to controls. 45 Analytics that use multiple data streams to effectively detect decompensation are already at work in some ICUs, and such use is expected to grow. Analytic tools are likely to make their way into other clinical settings as well to predict decompensation.
Some work has already been done in predicting readmissions, and analytics will play a key role in further work.
Adverse Events
Another use case for analytics will be to predict which patients are at risk of adverse events of several types. Adverse events are expensive 46 and cause substantial morbidity and mortality, yet many are preventable.
Renal Failure Renal failure is extremely expensive and carries a high risk of mortality. 47 However, renal function is readily measured, and early changes in it are often apparent well before major decompensation occurs. It seems likely that analytics could be combined with data about exposures to specific medications and with measures of kidney function, blood pressure, urine output, and other processes to identify patients at risk of decompensation.
Infection Analytics can be effective in managing infection. One example involves monitoring and interpreting changes in heart rate variability for detection of major decompensation in infants with very low birthweights before the emergence of an infection. 48 Monitoring the heart-rate characteristics of newborns alone has already resulted in reductions in mortality and increases in the number of ventilator-free days. However, there is room for improvement using increasingly sophisticated analytics that account for subtle signals 28 but also filter out extraneous patterns, 49 such as those that occur when the baby moves.
Adverse Drug Events Adverse drug events, which occur frequently 50 and are costly, 51 are another area where analytics can be effective. Most efforts so far to predict which patients will suffer an adverse drug event have not been very effective. 52, 53 However, analytics have the potential to predict with substantial accuracy which patient may suffer an adverse drug event and to detect patients who are in the early stages of such an event, by assessing genetic and genomic information, laboratory data, information on vital signs, and other data.
Diseases Affecting Multiple Organ Systems
Chronic conditions that span more than one organ system or are systemic in nature are some of the costliest conditions to manage. 54, 55 Any single disease may include cutaneous (skin), mucosal, renal, musculoskeletal, pulmonary, hematological, immunological, and neurologic manifestations. 56 Autoimmune disorders such as scleroderma, rheumatoid arthritis, and systemic lupus erythematosus are examples of such conditions.
The ability to accurately predict the trajectory of a patient's disease could allow the caregiver to better target complicated and expensive therapies to patients who stand to benefit the most from them, thus reducing the burden of disease on those patients and on the health care system. Currently, the caregiver's ability to optimize treatment is limited by the complexities resulting from the heterogeneity in clinical phenotypes, the diversity of available measurements, and lack of high-precision biomarkers. 57 This area is ripe for computing approaches that can combine the multitude of measurements taken as part of routine care to infer the progression of a patient's disease and tailor treatments to that patient. There are already some successful examples of these approaches. 58, 59 Multisite longitudinal registries that allow the aggregation of populations of patients with a disease or condition 60 have been initiated. In the near future, clinical data networks are likely to play the role that registries now do. One example of such a network is the National Patient-Centered Clinical Research Network (PCORnet), 61 which itself comprises multiple clinical data research networks. Access to longitudinal records has been the biggest limitation for making progress in the area of chronic diseases in multiple organ systems. As EHRs and clinical data networks based on EHRs become widespread, we expect to see the benefits of these technologies in improving care for patients with such diseases.
Discussion
We have discussed six use cases for high-risk patients in which clinical analytics are likely to be highly beneficial. This is by no means an exhaustive list. The evidence of benefit varies widely across the six use cases, but the current costs for the patients in each case are very great.
We focused in particular on use cases that include the hospital inpatient setting, in part because that is where the most data are available. However, analytics will almost certainly be useAnalytics will almost certainly be useful across the health care continuum.
ful across the health care continuum-for example, in evaluating the overall drivers of costs and using tools like geocoding (coding data by geography) to detect epidemics or to identify "hot spots" (of diseases, high costs, and so on). Both predicting outcomes of patients-such as who will be a high-cost patient, be readmitted, or suffer an adverse event-and tailoring the management of patients should result in substantial savings for the health care system.
One question is to what extent to use diseasespecific models versus more general ones in bigdata analytics in health care. Much of US health care organizations' focus in their use of analytics has been on patients with one condition, such as congestive heart failure. This approach can often be effective. However, we believe that approaches that address multiple conditions are likely to have a bigger impact on care outcomes and cost savings in the long run.
Another question is how to incorporate the narrative text from EHRs into big-data analytics in health care. Extracting clinically relevant concepts using natural language processing is difficult. 62, 63 Essential elements of the narrative, such as temporal relationships and co-references (that is, narrative that refers to more than one thing), may be lost or incorrectly assigned. 64, 65 Nonetheless, clinical natural language processing is already quite usable, and even simple approaches can find 90 percent of factual information of many types. 66, 67 A related problem is that longitudinal follow-up is hindered by the paucity of information exchange among health systems and registries of vital statistics.
Modern analytic approaches have shown demonstrable performance gains in other industries and are markedly different from the typical data analytic approaches used in health care. The health care system has generally used simple decision tree or logistic regression models, in part because these often have to be implemented under time constraints at the point of care.
EHRs make it possible to use models of diagnosis and care that combine thousands of disparate measurements to generate evidence in real time. These models can be far more complex than their predecessors: For example, instead of identifying one or two key markers, such as smoking and high blood pressure, complex analytic models can combine subtle cues from a large number of markers. This increased complexity makes the new models more difficult to interpret and their reliability less easy to assess, compared to previous models.
Other industries have grown accustomed to running mission-critical systems using such complex and advanced approaches while also establishing reliability-typically through extensive test implementations before deployment in production. Attention must be paid to the generalizability of existing results in models' performance to evaluate the size and scope of appropriate test implementations in health care. 16 Another limiting factor in the use of analytics in the health care setting has been delivering predictions to providers-especially in real time-to enable action. That is becoming progressively easier with EHRs and modern communication tools. However, many EHRs do not include robust event engines-tools that sift through data and use rules to notify providers when appropriate-or robust approaches for determining which provider is responsible for a specific patient at a given time.
Policy Implications
Our observations have a number of implications with respect to research, regulation, payment, and privacy, among other areas.
Research Regarding research, more systematic evaluation is needed to move from potential to realization in many areas. Specifically, we believe that federal support for research that evaluates the use of analytics and big data to address the six use cases discussed above is warranted. Especially useful would be studies of the tailoring of solutions for high-risk patients and the use of multiple streams of data-in particular, from sensor technologies-for the prediction of adverse events and for therapy selection for patients with diseases that affect multiple organ systems.
Yet to be determined is the extent to which hypothesis-driven (the traditional approach) or hypothesis-free approaches (such as those used in data mining) are appropriate. Also still unclear is the relative importance of developing specific approaches and of implementing and disseminating them. We believe that there is more need to develop approaches, because payFederal support for research that evaluates the use of analytics and big data to address the six use cases is warranted. ment reform is likely to offer strong incentives for their implementation and dissemination.
Regulation From the regulation perspective, a key question will be to what extent these predictive analytic approaches will be regulated by the Food and Drug Administration (FDA). In August 2013 the Food and Drug Administration Safety and Innovation Act working group tasked with evaluating emerging health information technology (IT) published a draft report concluding that FDA premarket review of health IT applications, such as analytics, would not be beneficial. 68 The report also concluded that if health IT applications used analytics to deliver strong clinical decision support or were embedded in devices, they might require FDA review. Thus, there is clearly a tension between the need for regulatory oversight and for protection of the public. The FDA has already released another report on this topic in 2014.
69
Payment With respect to payment, strategies such as the accountable care organization model that encourage organizations to invest in cost reduction will likely accelerate the adoption of analytics. However, as many experts have commented, the current provisions of the Affordable Care Act may not be sufficient on their own to get providers to focus on costs. 70 Privacy Regarding privacy, there are many thorny issues, as the growing controversy over the National Security Agency's collection of data about private phone calls has illustrated. Many people will not wish to have some types of data about them linked with other types of data, and this issue may be even more sensitive in health care than in other domains. However, Ruth Faden and coauthors have argued that in a just health care system, patients have a moral obligation to contribute to the common purpose of improving the quality and value of clinical care. 71 Policy makers have been reluctant to alter the provisions of the Health Information Portability and Accountability Act (HIPAA) of 1996, which is the major legislation related to privacy and security issues in health care. However, the act does not address many issues that will become relevant as more disparate data sources become linked.
Conclusion
Big data, including analytics, is a powerful tool that will be as useful in health care as it has been in other industries. The choice of these specific use cases that we have discussed in this article can be debated. Nonetheless, we believe that they will be among those that deliver the greatest value for health care organizations in the near term. This general approach has great potential for improving value in health care. We believe that organizations that employ it in many domains will benefit, especially under payment Current provisions of the Affordable Care Act may not be sufficient on their own to get providers to focus on costs.
